COVID-19 in children treated with immunosuppressive medication for kidney diseases

BACKGROUND: Children are recognised as at lower risk of severe COVID-19 compared with adults, but the impact of immunosuppression is yet to be determined. This study aims to describe the clinical course of COVID-19 in children with kidney disease taking immunosuppressive medication and to assess dis...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arch Dis Child
Päätekijät: Marlais, Matko, Wlodkowski, Tanja, Al-Akash, Samhar, Ananin, Petr, Bandi, Varun Kumar, Baudouin, Veronique, Boyer, Olivia, Vásquez, Luciola, Govindan, Sukanya, Hooman, Nakysa, Ijaz, Iftikhar, Loza, Reyner, Melgosa, Marta, Pande, Nivedita, Pape, Lars, Saha, Anshuman, Samsonov, Dmitry, Schreuder, Michiel F, Sharma, Jyoti, Siddiqui, Sahar, Sinha, Rajiv, Stewart, Heather, Tasic, Velibor, Tönshoff, Burkhard, Twombley, Katherine, Upadhyay, Kiran, Vivarelli, Marina, Weaver, Donald J, Woroniecki, Robert, Schaefer, Franz, Tullus, Kjell
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754669/
https://ncbi.nlm.nih.gov/pubmed/33355203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2020-320616
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia